ZENITHDRUG
Start SIP
Invest Now
Start SIP in ZENITHDRUG
Performance
- Low
- ₹46
- High
- ₹48
- 52 Week Low
- ₹45
- 52 Week High
- ₹107
- Open Price₹46
- Previous Close₹48
- Volume11,200
- 50 DMA₹51.42
- 100 DMA₹55.61
- 200 DMA₹62.06
Investment Returns
- Over 1 Month -1.64%
- Over 3 Month -19.6%
- Over 6 Month -26.15%
- Over 1 Year -39.16%
Smart Investing Starts Here Start SIP with Zenith Drugs for Steady Growth!
Zenith Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 11.3
- PEG Ratio
- -
- Market Cap Cr
- 81
- P/B Ratio
- 1.1
- Average True Range
- 2.63
- EPS
- 4.26
- Dividend Yield
- 0
- MACD Signal
- -0.56
- RSI
- 45.43
- MFI
- 47.23
Zenith Drugs Financials
Zenith Drugs Technicals
EMA & SMA
Current Price
₹47.00
-1.05
(-2.19%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹49.45
- 50 Day
- ₹51.42
- 100 Day
- ₹55.61
- 200 Day
- ₹62.06
Resistance and Support
48.18
- R3 48.87
- R2 48.68
- R1 48.37
- S1 47.87
- S2 47.68
- S3 47.37
Zenith Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results & Others | To consider Other business matters. Final Dividend of Re. 0.5 per equity share |
| 2025-05-29 | Audited Results & Others | To consider Other business matters. Final Dividend of Re. 0.5 per equity share |
| 2025-04-17 | To consider Fund Raising & Others | To consider Other business matters. (Revised) Final Dividend of Re. 0.5 per equity share |
| 2024-11-14 | Quarterly Results | |
| 2024-05-29 | Audited Results |
Zenith Drugs F&O
About Zenith Drugs
- NSE Symbol
- ZENITHDRUG
- BSE Symbol
- Managing Director
- Mr. Sandeep Bhardwaj
- ISIN
- INE0QWN01013
Similar Stocks to Zenith Drugs
Zenith Drugs FAQs
Zenith Drugs share price is ₹47 As on 12 February, 2026 | 14:35
The Market Cap of Zenith Drugs is ₹80.6 Cr As on 12 February, 2026 | 14:35
The P/E ratio of Zenith Drugs is 11.3 As on 12 February, 2026 | 14:35
The PB ratio of Zenith Drugs is 1.1 As on 12 February, 2026 | 14:35
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.